Nano-X Imaging Ltd. (NNOX)
USD 4.67
(-4.89%)
USD 4.67
(-4.89%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 55.99 Million USD | -25.2% |
| 2022 | 72.32 Million USD | 20.45% |
| 2021 | 60.04 Million USD | 36.71% |
| 2020 | 43.92 Million USD | 94.6% |
| 2019 | 22.57 Million USD | 1085.45% |
| 2018 | 1.9 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 10.93 Million USD | -5.26% |
| 2024 Q2 | 11.46 Million USD | 4.87% |
| 2023 Q4 | 11.54 Million USD | -10.5% |
| 2023 FY | 54.1 Million USD | -25.2% |
| 2023 Q3 | 12.89 Million USD | -19.43% |
| 2023 Q2 | 16 Million USD | 5.18% |
| 2023 Q1 | 15.21 Million USD | -8.03% |
| 2022 Q3 | 17.41 Million USD | -6.97% |
| 2022 Q2 | 18.72 Million USD | -6.5% |
| 2022 Q1 | 20.02 Million USD | -1.86% |
| 2022 FY | 72.32 Million USD | 20.45% |
| 2022 Q4 | 16.54 Million USD | -5.02% |
| 2021 Q4 | 20.4 Million USD | 51.41% |
| 2021 Q3 | 13.47 Million USD | -0.31% |
| 2021 Q1 | 12.65 Million USD | -33.63% |
| 2021 FY | 60.04 Million USD | 36.71% |
| 2021 Q2 | 13.51 Million USD | 6.85% |
| 2020 Q1 | 7.37 Million USD | -61.29% |
| 2020 Q4 | 19.06 Million USD | 72.31% |
| 2020 FY | 43.92 Million USD | 94.6% |
| 2020 Q3 | 11.06 Million USD | 72.06% |
| 2020 Q2 | 6.42 Million USD | -12.78% |
| 2019 Q3 | 1.86 Million USD | 96.12% |
| 2019 Q1 | 830.5 Thousand USD | 0.0% |
| 2019 FY | 22.57 Million USD | 1085.45% |
| 2019 Q2 | 953 Thousand USD | 14.75% |
| 2019 Q4 | 19.04 Million USD | 918.73% |
| 2018 FY | 1.9 Million USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Acutus Medical, Inc. | 11.22 Million USD | -398.904% |
| Cerus Corporation | 143.15 Million USD | 60.884% |
| OrthoPediatrics Corp. | 137.01 Million USD | 59.132% |
| PetVivo Holdings, Inc. | 11.36 Million USD | -392.894% |
| Talis Biomedical Corporation | 67.18 Million USD | 16.654% |
| Vivos Therapeutics, Inc. | 24.94 Million USD | -124.473% |
| Inogen, Inc. | 236.08 Million USD | 76.281% |
| Spectral AI, Inc. | 20.86 Million USD | -168.391% |
| CVRx, Inc. | 76.14 Million USD | 26.457% |
| DIH Holding US, Inc. Warrants | 3.52 Million USD | -1487.218% |
| Helius Medical Technologies, Inc. | 12.48 Million USD | -348.371% |
| Orthofix Medical Inc. | 667.42 Million USD | 91.61% |
| Venus Concept Inc. | 80.47 Million USD | 30.418% |
| Accelerate Diagnostics, Inc. | 56.57 Million USD | 1.027% |
| Bioventus Inc. | 409.91 Million USD | 86.339% |
| BrainsWay Ltd. | 28.01 Million USD | -99.861% |
| Envoy Medical, Inc. | 17.89 Million USD | -212.867% |
| electroCore, Inc. | 32.03 Million USD | -74.821% |
| IceCure Medical Ltd | 16.87 Million USD | -231.814% |
| Lucid Diagnostics Inc. | 42.43 Million USD | -31.969% |
| Monogram Orthopaedics, Inc. | 17.63 Million USD | -217.569% |
| MaxCyte, Inc. | 84.84 Million USD | 34.001% |
| NeuroOne Medical Technologies Corporation | 12.41 Million USD | -351.161% |
| Nexalin Technology, Inc. | 5.78 Million USD | -868.579% |
| PAVmed Inc | 64.82 Million USD | 13.621% |
| Rapid Micro Biosystems, Inc. | 51.07 Million USD | -9.63% |
| RxSight, Inc. | 103.85 Million USD | 46.079% |
| Sight Sciences, Inc. | 126.44 Million USD | 55.716% |
| SI-BONE, Inc. | 156.35 Million USD | 64.185% |
| TELA Bio, Inc. | 84.18 Million USD | 33.485% |
| TriSalus Life Sciences, Inc. | 70.05 Million USD | 20.068% |
| Treace Medical Concepts, Inc. | 203.36 Million USD | 72.465% |
| LivaNova PLC | 843.54 Million USD | 93.362% |
| 908 Devices Inc. | 68.08 Million USD | 17.748% |
| Alphatec Holdings, Inc. | 483.59 Million USD | 88.421% |
| Nemaura Medical Inc. | 7.13 Million USD | -684.403% |
| NeuroPace, Inc. | 75.29 Million USD | 25.631% |
| LENSAR, Inc. | 33.33 Million USD | -67.978% |
| Apyx Medical Corporation | 51.01 Million USD | -9.759% |
| Cutera, Inc. | 197.72 Million USD | 71.679% |
| STRATA Skin Sciences, Inc. | 24.78 Million USD | -125.967% |
| BioSig Technologies, Inc. | 28.53 Million USD | -96.274% |
| Anika Therapeutics, Inc. | 191.47 Million USD | 70.755% |
| ClearPoint Neuro, Inc. | 36.06 Million USD | -55.288% |
| Integra LifeSciences Holdings Corporation | 836.39 Million USD | 93.305% |
| Axonics, Inc. | 270.2 Million USD | 79.276% |
| Outset Medical, Inc. | 198.77 Million USD | 71.828% |
| IRIDEX Corporation | 31.81 Million USD | -76.014% |
| PROCEPT BioRobotics Corporation | 180.21 Million USD | 68.928% |
| IRadimed Corporation | 30.12 Million USD | -85.896% |
| Tivic Health Systems, Inc. | 8.53 Million USD | -556.317% |
| INVO Bioscience, Inc. | 7.85 Million USD | -613.038% |
| Telesis Bio, Inc. | 63.48 Million USD | 11.8% |
| Viemed Healthcare, Inc. | 98.45 Million USD | 43.123% |
| Varex Imaging Corporation | 224.8 Million USD | 75.09% |
| Quipt Home Medical Corp. | 148.66 Million USD | 62.334% |
| Inspira Technologies Oxy B.H.N. Ltd. | 11.72 Million USD | -377.668% |
| Pulmonx Corporation | 112.68 Million USD | 50.307% |
| Dynatronics Corporation | 9.9 Million USD | -465.168% |
| Modular Medical, Inc. | 17.52 Million USD | -219.453% |
| ReShape Lifesciences Inc. | 20.18 Million USD | -177.391% |
| Semler Scientific, Inc. | 38.94 Million USD | -43.789% |
| InMode Ltd. | 215.68 Million USD | 74.037% |
| Bruker Corporation | 1.07 Billion USD | 94.798% |
| Cytosorbents Corporation | 48.33 Million USD | -15.847% |
| DexCom, Inc. | 1.69 Billion USD | 96.689% |
| Align Technology, Inc. | 2.07 Billion USD | 97.304% |
| Viveve Medical, Inc. | 22.17 Million USD | -152.546% |
| ZimVie Inc. | 275.12 Million USD | 79.647% |
| Movano Inc. | 29.69 Million USD | -88.606% |
| Cytek Biosciences, Inc. | 137.27 Million USD | 59.207% |
| Nexalin Technology, Inc. | 5.78 Million USD | -868.579% |
| DIH Holdings US, Inc. Class A Common Stock | 3.52 Million USD | -1487.218% |
| Tandem Diabetes Care, Inc. | 600.92 Million USD | 90.681% |
| Profound Medical Corp. | 33.6 Million USD | -66.642% |
| Insulet Corporation | 939.9 Million USD | 94.042% |
| enVVeno Medical Corporation | 25.23 Million USD | -121.876% |
| Surmodics, Inc. | 98.69 Million USD | 43.264% |
| iCAD, Inc. | 22.22 Million USD | -151.955% |
| Nuwellis, Inc. | 22.61 Million USD | -147.632% |
| Biotricity, Inc. | 17.18 Million USD | -225.857% |
| iRhythm Technologies, Inc. | 445.88 Million USD | 87.441% |
| Aethlon Medical, Inc. | 12.27 Million USD | -356.094% |
| InspireMD, Inc. | 22.95 Million USD | -143.996% |
| PAVmed Inc. | 64.82 Million USD | 13.621% |
| BIOLASE, Inc. | 34.66 Million USD | -61.556% |
| Beyond Air, Inc. | 61.7 Million USD | 9.243% |
| FONAR Corporation | 28.6 Million USD | -95.762% |
| AxoGen, Inc. | 149.33 Million USD | 62.503% |
| Vivani Medical, Inc. | 26.96 Million USD | -107.665% |
| Tactile Systems Technology, Inc. | 177.09 Million USD | 68.38% |
| Inari Medical, Inc. | 448.59 Million USD | 87.517% |
| UFP Technologies, Inc. | 58.08 Million USD | 3.601% |
| QT Imaging Holdings, Inc. | 4.92 Million USD | -1036.395% |
| Heart Test Laboratories, Inc. | 6.31 Million USD | -786.268% |
| Tenon Medical, Inc. | 16.96 Million USD | -230.015% |
| Autonomix Medical, Inc. Common Stock | 7.39 Million USD | -657.433% |
| Co-Diagnostics, Inc. | 44.1 Million USD | -26.969% |
| AdaptHealth Corp. | 1.07 Billion USD | 94.805% |
| Sintx Technologies, Inc. | 15.2 Million USD | -268.377% |
| NanoVibronix, Inc. | 4.97 Million USD | -1026.021% |
| Quanterix Corporation | 118.1 Million USD | 52.585% |
| Inspira Technologies Oxy B.H.N. Ltd. | 11.72 Million USD | -377.668% |
| Sensus Healthcare, Inc. | 14.44 Million USD | -287.737% |
| Pacific Biosciences of California, Inc. | 392.66 Million USD | 85.739% |
| TransMedics Group, Inc. | 182.82 Million USD | 69.37% |
| ReWalk Robotics Ltd. | 28.06 Million USD | -99.526% |
| NeuroMetrix, Inc. | 11.09 Million USD | -404.526% |
| Hyperfine, Inc. | 52.87 Million USD | -5.911% |
| Establishment Labs Holdings Inc. | 172 Million USD | 67.444% |
| Biomerica, Inc. | 6.97 Million USD | -702.479% |
| Bone Biologics Corporation | 9.42 Million USD | -493.924% |
| AVITA Medical, Inc. | 80.77 Million USD | 30.679% |
| Bluejay Diagnostics, Inc. | 10.31 Million USD | -443.069% |
| Silk Road Medical, Inc | 186.35 Million USD | 69.952% |